Skip to main content
About
Contact
Subscribe
e-Edition
Make Home Page
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Twitter
Toggle navigation
Site search
Search
Home
Contact Us
Advertise
Subscription Services
Promote Your Event
Submission Forms
News
Local News
National
World
Archives
Sports
Local Sports
National Sports
Business
Local Business
National Business
Technology
Markets & Stocks
Opinion
Columns
Editorials
Letters To The Editor
Polls
Thumbs
A & E
Local Entertainment
Art Scene
Music Scene
Theatre Scene
Book Reviews
Movie Reviews
TV Listings
Local Events
What To Do
Life
Health
Travel
Oddities
Community Directory
Community Service
Rescue Me
Other
Magazines
Fall Home Improvements 2024
Women
Home & Realty
Outdoor Guide
Premier Home Style Tour 2024
Spring Home & Garden Show 2025
Spring on the Road
Spring Wellness 2025
Canada Votes 2025
Classifieds
Place Ad
Careers
Tenders
Weather
Obituaries
Parcel Pickup
Ontario Votes
Auction 2025
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Latest News about alzheimer's
Recent news which mentions alzheimer's
Cassava Sciences Discontinues Developing Simufilam For Alzheimer's After Another Phase 3 Trial Flop
March 25, 2025
Tickers
NEWS
SAVA
Tags
Briefs
Market News
Movers
From
Benzinga
Alpha Cognition Is 'Under-Followed' As Alzheimer Drug Targets $2 Billion Long Term Care Market: Analyst
March 18, 2025
Tickers
ACOG
JNJ
NEWS
Tags
Briefs
JNJ
Market News
From
Benzinga
Cannabinoid Drug For Agitation In Alzheimer's Yields Cognitive Improvements In Clinical Trial
November 26, 2024
Tickers
IGC
NEWS
Tags
Market News
Cannabis
IGC/AD1
From
Benzinga
Eli Lilly Says New Data Can Potentially Provide Path To Improved Donanemab Profile By Lower Risk Of Imaging Abnormalities In Patients With Early Alzheimer's
October 29, 2024
Tickers
LLY
NEWS
Tags
Market News
Briefs
Large Cap
From
Benzinga
AbbVie Chart Reflects Bearish Signals Ahead Of Q3 Earnings
October 29, 2024
Tickers
ABBV
SHL
Tags
Market News
Health Care
Trading Ideas
From
Benzinga
EXCLUSIVE: Nexalin Technology Says New Data Confirms Implantable Device Improves Cognitive Function, Restores Brain Activity in Alzheimer's Patients
October 28, 2024
Tickers
NEWS
NXL
NXLIW
Tags
Market News
Briefs
NXL
From
Benzinga
EXCLUSIVE: Nano-Cap Nexalin's Drug-Free Alternative For Alzheimer's Shows Improved Memory, Cognitive Function In Small Study
October 17, 2024
Tickers
NEWS
NXL
NXLIW
Tags
Market News
NXL
Briefs
From
Benzinga
After Disappointing Parkinson's Data, Sage Therapeutics' Dalzanemdor Flunks Mid-Stage Alzheimer's Study
October 08, 2024
Tickers
BIIB
NEWS
SAGE
Tags
SAGE
Health Care
News
From
Benzinga
Athira Pharma's Alzheimer's Candidate Fails To Improve Cognition And Function In Patients With Mild/Moderate Disease, Stock Sinks
September 04, 2024
Tickers
ATHA
NEWS
Tags
Market News
Movers
Briefs
From
Benzinga
Cassava Sciences Cooperates With DOJ, SEC On Controversial Alzheimer's Drug Investigation
July 01, 2024
Tickers
NEWS
SAVA
Tags
General
why it's moving
Top Stories
From
Benzinga
Alzheimer's Drug Trial Results Questioned After 'Damning' FDA Inspection Report
March 11, 2024
Tickers
NEWS
SAVA
Tags
FDA
Kaustubh Bagalkote
Market News
From
Benzinga
Alzheimer's Disease Vaccines: Promising Developments, Renewed Enthusiasm From Biogen, Eli Lilly And Others
November 21, 2023
Tickers
ACIU
BIIB
ESAIY
ESALY
Tags
BIIB
alzheimer's
Benzinga
From
Benzinga
FDA Approves Biogen's Alzheimer's Drug: Here Are Other Companies With Treatments In The Pipeline
July 07, 2023
Tickers
ALZN
BIIB
LLY
SAVA
Tags
General
BIIB
alzheimer's
From
Benzinga
Tesla, Amazon, Microsoft, Cassava Sciences, Intuitive Surgical: Why These 5 Stocks Are Drawing Investors' Attention Today
January 24, 2023
Tickers
AMZN
ISRG
MSFT
SAVA
Tags
Earnings
electric vehicles
AMZN
From
Benzinga
Psychedelics For Alzheimer's And Stress-Induced Disorders Under Study At Columbia University
October 18, 2022
Tickers
SILO
Tags
Market News
Psilocybin
Markets
From
Benzinga
Nasdaq Futures Slip But S&P 500, Dow Futures Hold Up Ahead Of Market Open — Apple, Biogen Stocks In Focus
September 28, 2022
Tickers
AAPL
BIIB
QQQ
SPY
Tags
S&P 500 futures
Benzinga
alzheimer's
From
Benzinga
Why Biogen Stock Is Up 40% Today
September 28, 2022
Tickers
BIIB
ESALY
Tags
News
Trading Ideas
Market News
From
Benzinga
Brain Awareness Month: Bittersweet glimpse into early-dementia via video by Entertainer Carissa Biele
June 21, 2022
Tickers
VNUE
Tags
Media
music
country
From
PRUnderground
Benzinga's Daily Brief On Trending Tickers For April 19, 2022: Plug Power, Twitter, Cassava Sciences And More
April 19, 2022
Tickers
AXSM
JNJ
PLUG
RBLX
Tags
wallstreetbets
UBER
Crowdsourcing
From
Benzinga
IGC THC-Drug For Alzheimer's Symptoms Proved Safe & Effective, Pending FDA Approval For More Trials
December 14, 2021
Tickers
IGC
THC
Tags
Market News
Markets
Cannabis
From
Benzinga
The Walk To End Alzheimer’s Partnership
November 01, 2021
Tags
Book Scanning
Digitizing Memories
VHS to DVD
From
PRUnderground
Digital therapeutics startup Neuroglee raises $10M to help people with neurodegenerative conditions
September 09, 2021
Tickers
ASIA
TC
Tags
Southeast Asia
neurodegenerative disease
TC
From
TechCrunch
FDA Narrows Label To Recommend Use Of Biogen's Aduhelm In Mild Alzheimer's Patients
July 08, 2021
Tickers
BIIB
ESALY
Tags
ESALY
Aduhelm
Market News
From
Benzinga
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms Of Service
.